Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Go, no-go decision making for phase 3 clinical...
Journal article

Go, no-go decision making for phase 3 clinical trials: ACT IV revisited – Authors' reply

Authors

Weller M; Butowski N; Tran DD; Recht LD; Lim M; Hirte H; Ashby L; Mechtler L; Goldlust SA; Iwamoto F

Journal

The Lancet Oncology, Vol. 18, No. 12, pp. e709–e710

Publisher

Elsevier

Publication Date

12 2017

DOI

10.1016/s1470-2045(17)30856-2

ISSN

1470-2045